Clinical Trial Update: Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002 [Phase 3]

View source ↗

Summary

OPKO Health's extension study of CTAP101-CL-3001 or CTAP101-CL-3002 has completed Phase 3 and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism
• Vitamin Deficiency

Drugs mentioned

• CTAP101-CL-3001
• CTAP101-CL-3002

Snippet

Sponsor: OPKO Health, Inc. | Conditions: Chronic Kidney Disease, Hyperparathyroidism, Secondary | Phase 3 | Status: COMPLETED | Results posted: 2016-08-17